TETRACAINE HYDROCHL

The contract is for Tetracaine Hydrochloride 1% Injection, 20mg/2ml (10mg/ml), preservative-free in 2ml single-use vials, with ten vials per package, requiring refrigerated storage. The item is classified under NSN 6505-01-708-3073 with a unit of issue of a package (PG) and a quantity of one package. It has a non-extendable shelf life of 36 months and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-2073-1E and marking requirements per Medical Marking Standard No. 1, which supersedes MIL-STD-129. The manufacturer is BPI, Inc. with NDC code 54288-0127-10, and the product is regulated by the FDA, requiring a referral through EBS for confirmation. Delivery is FOB destination within 20 days to Fort Campbell, Kentucky, and shipment must be via traceable means, excluding parcel post. Packaging must ensure protection from damage, use commercial containers, and meet DLA packaging requirements, with palletization and marking strictly adhering to specified protocols. The contract was issued under solicitation SPE2DP-26-T-4231 with a response deadline of July 27, 2026, and the required delivery date is March 5, 2026.